Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,28117,300 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2025

ABSTRACT Pelvic organ tumors in men and women are projected to account for 40% and 18%, respectively, of new cancers diagnosed, and 31% and 26%, respectively, of cancer related dea...

$4.28M
USD
Completed NON-SBIR/STTR RPGS
Targeting colorectal cancer stem cells with ALDH1B1 antagonists
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Colorectal cancer is the third most common malignancy in the world, with approximately 1.4 million new cases and 700,000 deaths each year.Global incidence rates are expected to esc...

$4.12M
USD
Completed NON-SBIR/STTR RPGS
Self-assembled iron(III) hosts for MRI-guided delivery of chemotherapeutics
NATIONAL CANCER INSTITUTE State University of New York At Buffalo United States 2021 – 2023

Abstract Image-guided drug delivery is a promising approach to improve tumor uptake and to prevent the accumulation of toxic chemotherapeutic agents in healthy tissue. The imaging...

$2.01M
USD
Completed NON-SBIR/STTR RPGS
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

Abstract Homologous recombination (HR) is an important DNA repair mechanism for DNA damage caused by PARPi and platinum. The HR pathway is closely associated with ovarian cancer de...

$3.64M
USD
Completed NON-SBIR/STTR RPGS
Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization
NATIONAL CANCER INSTITUTE State University of New York At Buffalo United States 2021 – 2026

Cancer is a major cause of morbidity and mortality in the US, with 1.8 million cases and 600 thousand cancer deaths projected for 2020.Substantial progress in cancer treatment has...

$3.63M
USD
Completed RESEARCH CENTERS
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2022

SUMMARY ABSTRACT Single cell RNA profiling and DNA sequencing has revolutionized our understanding of the tumor microenvironment (TME) but such data lacks the spatial context and m...

$2.54M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic understanding of the lifecycle of a circulating hybrid cell
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Metastatic disease accounts for >90% of cancer-related deaths worldwide, yet this phase of tumor progression is the least biologically understood.The consequence of this lack of...

$6.33M
USD
Completed NON-SBIR/STTR RPGS
B cell antigen receptor (BCR)-driven mechanistic connection between B cell lymphomagenesis and autoimmunity
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Title: B cell antigen receptor (BCR)-driven mechanistic connection between B cell lymphomagenesis and autoimmunity Non-Hodgkin's lymphomas (NHL) are a...

$3.58M
USD
Completed OTHER RESEARCH-RELATED
Lipid-based Cancer Therapeutics
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2025

Project Summary Significant progress in human cancer therapy in the last decade has been driven by conceptionally new approaches to targeting cancer, including cancer immunotherapy...

$832.7K
USD
Completed NON-SBIR/STTR RPGS
Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2025

Racial disparities in colorectal cancer (CRC) incidence persist for blacks and whites.Given the previous work of our team documenting racial differences in the gut microbiota of bl...

$3.85M
USD
Completed NON-SBIR/STTR RPGS
Integrators of Metastatic Potential
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2024

Metastases cause major morbidities and nearly all of deaths in patients with breast cancer and other solid tumors.Our preliminary studies point to an intracellular signaling molecu...

$984.5K
USD
Completed NON-SBIR/STTR RPGS
Subcellular Enzyme-instructed self-assembly for molecular anticancer nanomedicines
NATIONAL CANCER INSTITUTE Brandeis University United States 2021 – 2023

ABSTRACT Despite the progress in molecular therapy and immunotherapy, multiple underlying cellular mechanisms cause resistance to cancer therapy. There are urgent needs to develop...

$512.4K
USD
Completed NON-SBIR/STTR RPGS
Obesity, Metabolism and Breast Cancer Metastasis
NATIONAL CANCER INSTITUTE Purdue University United States 2021 – 2023

Obesity, metabolic reprogramming, and breast cancer metastasis: Role of extracellular vesicles Abstract Obesity increases the risk of triple-negative breast cancer(TNBC) and its pr...

$1.17M
USD
Completed NON-SBIR/STTR RPGS
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Moderating Role of Residential Location (Diversity Supplement for V. Patterson)
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2021 – 2023

Despite increased survival,1 over two-thirds of children with cancer experience late effects, such as secondary cancers, sensorimotor deficits, and neurocognitive impairment.2,3 Ps...

$342.2K
USD
Completed OTHER RESEARCH-RELATED
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary/Abstract Prostate cancer (PCa) is the second most incident cancer in men worldwide and despite vast amounts of research, treatment of this disease remains elusive.T...

$754.9K
USD
Completed OTHER RESEARCH-RELATED
Patient-Centered Decision-Making for Management of Small Renal Tumors - Supplement
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2022

Project Summary The current treatment paradigm for small kidney tumors (? 4 cm) has resulted in worsened overall survival despite earlier detection and aggressive treatment with su...

$1.3M
USD
Completed NON-SBIR/STTR RPGS
SPHERE (Survivorship Plan Health Record) Implementation Trial
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The Institute of Medicine recommends that each cancer patient receive a survivorship care plan that summarizes information important to the individual’s lo...

$6.18M
USD
Completed SBIR-STTR RPGS
A System for Xerostomia Risk Classification after Head & Neck Cancer Radiotherapy
NATIONAL CANCER INSTITUTE Oncospace, Inc United States 2021 – 2022

Project Summary/Abstract Head and neck cancer (HNC) patients survive years after oncologic therapy due to increased efficacy of therapy, increased incidences of human papilloma vir...

$1.21M
USD
Completed NON-SBIR/STTR RPGS
Targeting colorectal cancer stem cells with ALDH1B1 antagonists
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Colorectal cancer is the third most common malignancy in the world, with approximately 1.4 million new cases and 700,000 deaths each year. Global incidence rates are expected to es...

$4.32M
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Role of Epigenetic Plasticity in anti-GD2 Immunotherapy Response
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2023

Project Summary Ganglioside GD2 is expressed on the cell surface of numerous pediatric cancers, including Ewing sarcoma, osteosarcoma, and neuroblastoma. In 2015, FDA approval of t...

$696.7K
USD